Buscar resultados de ensayos clínicos
Merkel Cell Carcinoma - 28 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) Condición:
|
Active, not recruiting |
Nombre del estudio: Merkel Positron Emission Tomography (PET) Protocol Condición: Merkel Cell Carcinoma Fecha: 2009-11-12 Intervenciones:
|
Recruiting |
Nombre del estudio: Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200) Condición: Carcinoma, Merkel Cell Fecha: 2014-06-02 Intervenciones: Drug: Avelumab Avelumab will be administered at a dose of 10 milligram per kilogram (mg/kg) as 1-hour in |
Recruiting |
Nombre del estudio: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma Condición:
Fecha: 2017-03-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma Condición:
|
Completed |
Nombre del estudio: S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer Condición: Neuroendocrine Carcinoma of the Skin Fecha: 1999-11-01 Intervenciones:
|
Recruiting |
Nombre del estudio: A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors Condición:
|
Active, not recruiting |
Nombre del estudio: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer Condición:
|
Recruiting |
Nombre del estudio: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues Condición: Carcinoma, Merkel Cell Fecha: 2015-01-13 Intervenciones: Drug: Lanreotide Other Name: Somatuline |
Completed |
Nombre del estudio: S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Condición:
|